Insulet Corp (PODD)
184.36
+7.96
(+4.51%)
USD |
NASDAQ |
May 07, 16:00
184.36
0.00 (0.00%)
After-Hours: 17:01
Insulet Research and Development Expense (TTM): 205.00M for Dec. 31, 2023
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 205.00M |
| September 30, 2023 | 212.50M |
| June 30, 2023 | 199.70M |
| March 31, 2023 | 187.20M |
| December 31, 2022 | 180.20M |
| September 30, 2022 | 172.50M |
| June 30, 2022 | 165.00M |
| March 31, 2022 | 162.50M |
| December 31, 2021 | 160.10M |
| September 30, 2021 | 156.60M |
| June 30, 2021 | 157.90M |
| March 31, 2021 | 152.00M |
| December 31, 2020 | 146.80M |
| September 30, 2020 | 144.00M |
| June 30, 2020 | 136.50M |
| March 31, 2020 | 135.30M |
| December 31, 2019 | 132.30M |
| September 30, 2019 | 130.20M |
| June 30, 2019 | 121.23M |
| March 31, 2019 | 107.03M |
| December 31, 2018 | 94.80M |
| September 30, 2018 | 81.43M |
| June 30, 2018 | 79.24M |
| March 31, 2018 | 78.47M |
| December 31, 2017 | 75.70M |
| Date | Value |
|---|---|
| September 30, 2017 | 71.70M |
| June 30, 2017 | 65.30M |
| March 31, 2017 | 60.22M |
| December 31, 2016 | 55.71M |
| September 30, 2016 | 52.57M |
| June 30, 2016 | 48.87M |
| March 31, 2016 | 47.99M |
| December 31, 2015 | 43.21M |
| September 30, 2015 | 37.60M |
| June 30, 2015 | 34.72M |
| March 31, 2015 | 29.33M |
| December 31, 2014 | 27.90M |
| September 30, 2014 | 27.04M |
| June 30, 2014 | 25.65M |
| March 31, 2014 | 24.15M |
| December 31, 2013 | 21.76M |
| September 30, 2013 | 21.19M |
| June 30, 2013 | 21.98M |
| March 31, 2013 | 23.32M |
| December 31, 2012 | 24.36M |
| September 30, 2012 | 24.32M |
| June 30, 2012 | 22.40M |
| March 31, 2012 | 22.71M |
| December 31, 2011 | 21.86M |
| September 30, 2011 | 20.50M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
121.23M
Minimum
Jun 2019
212.50M
Maximum
Sep 2023
160.92M
Average
157.90M
Median
Jun 2021
Research and Development Expense (TTM) Benchmarks
| Abbott Laboratories | 2.771B |
| Stryker Corp | 1.417B |
| Tandem Diabetes Care Inc | 173.75M |
| Becton Dickinson & Co | 1.176B |
| ResMed Inc | 304.81M |